Braden Schuster, MD
Pain Medicine · Columbia, TNNPI 1023515897
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,157 of the $5,910 with a category attached, or 70.3%. 9 manufacturers reported payments, led by Boston Scientific at 46.5% of the total. Reporting peaked in 2024 at $2,243 and has fallen 68.4% since, to $708 in 2025.
Across 135 payments — averaging $43.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Abbott$1K
- Medtronic$1K
- SPR Therapeutics, Inc$199
- Saluda Medical Americas, Inc.$47
- Stratus Medical, LLC$41
- plus $58 from 3 others
What the payments were for
- Travel & lodging$1,75430%
- Food & beverage$4,15770%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 88 | $2,749 |
| Abbott | 23 | $1,442 |
| Medtronic | 15 | $1,374 |
| SPR Therapeutics, Inc | 4 | $199 |
| Saluda Medical Americas, Inc. | 1 | $47 |
| Stratus Medical, LLC | 1 | $41 |
| Painteq LLC | 1 | $22 |
| Nevro Corp. | 1 | $20 |
| Avanos Medical | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,910 in reported general payments places this provider in the 60th percentile of 112 pain medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 154 | $4,747 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 183 | $4,466 |
| Tramadol Hcl | 121 | $3,117 |
| Buprenorphine | 11 | $1,816 |
| Pregabalin | 93 | $1,746 |
| Naloxone Hcl | 28 | $1,746 |
| Gabapentin | 145 | $1,517 |
| Morphine Sulfate ErMorphine Sulfate | 28 | $1,393 |
| Celecoxib | 41 | $774 |
| Duloxetine Hcl | 51 | $707 |
| Oxycodone Hcl | 30 | $556 |
| Diclofenac Sodium | 14 | $463 |
| Morphine Sulfate | 11 | $368 |
| Nortriptyline Hcl | 25 | $200 |
| Tizanidine Hcl | 25 | $140 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Columbia
- Shravani DurbhakulaNashville$353K
- Joseph DichiaraKnoxville$102K
- Stephanie VanterpoolKnoxville$69K
- Herbert MeltzerNashville$43K
- Marc HuntoonNashville$37K
- Gregory BallChattanooga$35K
- Phillip GreenMemphis$34K
- Puneet MishraNashville$32K
- John BlakeChattanooga$28K
- Andrew DudasMemphis$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.